Czech Republic
· Delayed Price · Currency is CZK Pilulka Lékárny a.s. Statistics
Total Valuation
Pilulka Lékárny a.s. has a market cap or net worth of CZK 305.85 million. The enterprise value is 369.87 million.
| Market Cap | 305.85M |
| Enterprise Value | 369.87M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Pilulka Lékárny a.s. has 2.71 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 2.71M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| PB Ratio | 9.31 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.11 |
| EV / Sales | 0.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.29 |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 2.51.
| Current Ratio | 0.71 |
| Quick Ratio | 0.45 |
| Debt / Equity | 2.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.10 |
| Interest Coverage | -14.18 |
Financial Efficiency
Return on equity (ROE) is -207.35% and return on invested capital (ROIC) is -56.04%.
| Return on Equity (ROE) | -207.35% |
| Return on Assets (ROA) | -17.76% |
| Return on Capital (ROIC) | -56.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 4.08 |
| Inventory Turnover | 12.95 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.82% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -46.82% |
| 50-Day Moving Average | 134.96 |
| 200-Day Moving Average | 165.36 |
| Relative Strength Index (RSI) | 27.20 |
| Average Volume (20 Days) | 2,286 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pilulka Lékárny a.s. had revenue of CZK 2.13 billion and -174.94 million in losses. Loss per share was -64.63.
| Revenue | 2.13B |
| Gross Profit | 297.34M |
| Operating Income | -148.57M |
| Pretax Income | -175.87M |
| Net Income | -174.94M |
| EBITDA | -125.75M |
| EBIT | -148.57M |
| Loss Per Share | -64.63 |
Balance Sheet
The company has 10.85 million in cash and 77.00 million in debt, giving a net cash position of -66.16 million or -24.44 per share.
| Cash & Cash Equivalents | 10.85M |
| Total Debt | 77.00M |
| Net Cash | -66.16M |
| Net Cash Per Share | -24.44 |
| Equity (Book Value) | 30.71M |
| Book Value Per Share | 12.14 |
| Working Capital | -116.31M |
Cash Flow
In the last 12 months, operating cash flow was -34.29 million and capital expenditures -35.63 million, giving a free cash flow of -69.92 million.
| Operating Cash Flow | -34.29M |
| Capital Expenditures | -35.63M |
| Free Cash Flow | -69.92M |
| FCF Per Share | -25.83 |
Margins
Gross margin is 13.95%, with operating and profit margins of -6.97% and -8.21%.
| Gross Margin | 13.95% |
| Operating Margin | -6.97% |
| Pretax Margin | -8.25% |
| Profit Margin | -8.21% |
| EBITDA Margin | -5.90% |
| EBIT Margin | -6.97% |
| FCF Margin | n/a |
Dividends & Yields
Pilulka Lékárny a.s. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -57.20% |
| FCF Yield | -22.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pilulka Lékárny a.s. has an Altman Z-Score of 3.49.
| Altman Z-Score | 3.49 |
| Piotroski F-Score | n/a |